期刊文献+

睑板腺癌nm23基因mRNA和c-myc基因的表达 被引量:3

Expressions of nm23 and c- myc in Meibomian Gland Carcinoma
下载PDF
导出
摘要 目的 :探讨nm2 3和c myc基因表达与睑板腺癌生物学行为的关系。方法 :采用原位杂交技术和免疫组化SABC法对 3 3例睑板腺癌石蜡切片中nm2 3和c myc基因的表达进行研究。 结果 :睑板腺癌nm2 3基因mRNA阳性表达率为 4 8.5 % ( 16/ 3 3 ) ,c myc基因阳性表达率为 5 4 .5 % ( 18/ 3 3 )。ⅡⅢ度睑板腺癌nm2 3基因mR NA表达阳性率为 63 .6% ( 14 / 2 2 ) ,Ⅰ度为 18.2 % ( 2 / 11) ,二者比较P <0 .0 5 ,中、低分化睑板腺癌nm2 3基因mR NA阳性表达率为 60 .9% ( 14 / 2 3 ) ,高分化癌nm2 3基因mRNA阳性率为 2 0 % ( 2 / 10 ) ,P <0 .0 5。ⅡⅢ度睑板腺癌c myc基因阳性表达率为 68.2 % ( 15 / 2 2 ) ,Ⅰ度为 2 7.3 % ( 3 / 11) ,P <0 .0 5 ;中低分化睑板腺癌c myc基因阳性表达率为 69.6% ( 16/ 2 3 ) ,高分化癌为 2 0 % ( 2 / 10 ) ,P <0 .0 5。nm2 3基因与c myc基因表达相关性检验 ,P >0 .0 5。结论 :nm2 3和c myc基因与睑板腺癌的发生、发展有关 ,与睑板腺癌分化程度密切相关 ,可能是判断其恶性程度的指标之一。 Objective: Our purpose was to investigate the relationship between expressions of nm23, c myc and biological progress of meibomian gland carcinoma. Methods: Expressions of nm23 and c myc were evaluated with in situ hybridization and immunohistochemical SABC method in 33 patients with meibomian gland carcinoma. Results: Positive rate of nm23 mRNA in meibomian gland carcinoma was 48.5% (16/33), and positive rate of c myc expression was 54.6% (18/33). Expression of nm23 was positive in 60.9% (14/23) of grade 2 to 3, 18.2% (2/11) in grade 1 (P< 0.05 ). Positive rate of nm23 in poorly differentiated group was 60.9% (14/23) and 20%(2/10) in well differentiated group (P<0.05). Positive expression of c myc in grade 1 to 2 was 68.2% (15/22), and 27.3% (3/11) in grade 1 (P<0.05). Positive rate of c myc in poorly differentiated group was 69.6% (16/23) and 20% (2/10) in well differentiated group(P<0.05). Conclusion: The gene of nm23 and c myc is related to the formation of meibomian gland carcinoma, which associated with the progress of its development and differentiation. They may act as malignant predictors in meibomian gland carcinoma.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2001年第4期311-313,共3页 Journal of China Medical University
关键词 睑板腺癌 NM23基因 mRNA C-MYC基因 基因表达 meibomian gland carcinoma nm23 c myc gene
  • 相关文献

参考文献4

  • 1曾水清.睑板腺癌15例临床分析[J].中华眼科杂志,1980,16(2):146-147.
  • 2Zeng Z S,Br J Cancer,1994年,70卷,5期,1025页
  • 3Gopal V,Leukemia Res,1992年,16卷,10期,1003页
  • 4曾水清,中华眼科杂志,1980年,16卷,2期,146页

共引文献4

同被引文献39

  • 1孙为荣.眼科病理学.第1版.北京:人民卫生出版社,1996:589-593.
  • 2Yen MT, Tse DT, Wu X, et al. Radiation therapy for local control of eyelid sebaceous cell carcinoma : report of two cases and review of the literature. Ophthal Palast Reeonstr Surg 2000; 16( 3 ) :211-215
  • 3Pardo FS, Wang CC, Albert D, et al. Sebaceous carcinoma of the ocular adnexa: radiotherapeutic management. Int J Radiat Oncol Biol Phys 1989 ; 17 ( 3 ) : 643- 647
  • 4Rao NA, Hidayat AA, Mclean IE. Sebaceous carcinoma of tile ocular adnexa :A clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol 1982 ; 13 ( 2 ) : 113-122
  • 5Chen XF, Zhang HT, Qi QY, et al. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human nonsmall cell lung cancer in China. Lung Cancer 2004;109 ( 1 ) :65-70
  • 6Spencer JM, Nossa R, Tse DT, et al. Sebaeeous carcinoma of the eyelid treated with Mohs micrographie surgery.J Am Aead Dermatol 2001; 44(6) :1004-1009
  • 7Valenzuela-Flores G, Mozas-Davila D, Rodriguez-Reyes AA, et al. Sebaceous gland carcinoma of the eyelids. Cir Cir 2006 ;74 ( 6 ) :509-510
  • 8Yaleinkaya U, Ozuysal S, Bilgin T, et al. Nnt23 expression in nodepositive and node-negative endometrial cancer. Int J Gynaecol Obstet 2006 ;95 ( 1 ) :35-39
  • 9Bakalian S, Marshall JC, Faingold D et al. Expression of nm23-H1 in uveal melanoma. Melanoma Res 2007 ; 17 (5) :284-290
  • 10Kass LG,Hornblass A.Sebaceous carcinoma of the ocular adnexa[J].Surv Ophthalmol 1989;33:477-490.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部